Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2012 1
2013 2
2014 5
2015 3
2016 6
2017 3
2018 3
2019 6
2020 22
2021 14
2022 15
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for yongxiang yi
Search for Yongning Yi instead (2 results)
Blockade of IL-33 signalling attenuates osteoarthritis.
He Z, Song Y, Yi Y, Qiu F, Wang J, Li J, Jin Q, Sacitharan PK. He Z, et al. Among authors: yi y. Clin Transl Immunology. 2020 Oct 23;9(10):e1185. doi: 10.1002/cti2.1187. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33133598 Free PMC article.
TH17 cells…Sorting the good out from the bad.
Li J, Jiang L, Yi Y, Sacitharan PK. Li J, et al. Among authors: yi y. Signal Transduct Target Ther. 2020 Sep 19;5(1):207. doi: 10.1038/s41392-020-00316-2. Signal Transduct Target Ther. 2020. PMID: 32951000 Free PMC article. No abstract available.
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Yi C, Yi Y, Li J. Yi C, et al. Among authors: yi y. Virol Sin. 2020 Jun;35(3):259-262. doi: 10.1007/s12250-020-00243-0. Epub 2020 Jun 10. Virol Sin. 2020. PMID: 32524253 Free PMC article. No abstract available.
Targeting IL-22 and IL-22R protects against experimental osteoarthritis.
Yi C, Yi Y, Wei J, Jin Q, Li J, Sacitharan PK. Yi C, et al. Among authors: yi y. Cell Mol Immunol. 2021 May;18(5):1329-1331. doi: 10.1038/s41423-020-0491-y. Epub 2020 Jul 7. Cell Mol Immunol. 2021. PMID: 32636527 Free PMC article. No abstract available.
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study.
Fan X, Dai X, Ling Y, Wu L, Tang L, Peng C, Huang C, Liu H, Lu H, Shen X, Zhang W, Wang F, Li G, Li M, Huang Y, Zhang H, Li M, Ren F, Li Y, Liu C, Zhou Z, Sun W, Yi Y, Zhou D, Gao H, Pan Q, Liu H, Zhao J, Ding Z, Ma Y, Li W, Wang Q, Wang X, Bai Y, Jiang X, Ma J, Xie B, Zhang K, Li L. Fan X, et al. Among authors: yi y. Lancet Infect Dis. 2024 Feb;24(2):129-139. doi: 10.1016/S1473-3099(23)00577-7. Epub 2023 Nov 22. Lancet Infect Dis. 2024. PMID: 38006892 Clinical Trial.
84 results